Pillstats
Rx only · Capsule · Oral

Cephalexin

Cephalexin

29 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US139 NDCs
29 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2231
US makers31 labelers
Packages403
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 26 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.169$0.337$0.506$0.675Dec 2025Apr 2026Jul 2026
$0.482
Latest avg · Jul 22, 2026
-18%
Since Dec 17, 2025
29
Active US suppliers
24%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

453K906K1.4M1.8M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2M
Rx · 2026 Q1
28.2M
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it29 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
A-S Medication Solutionsunknown57SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown41SUPPLYING
Bryant Ranch Prepackrepackager37SUPPLYING
NuCare Pharmaceuticals, Inc.unknown36SUPPLYING
Proficient Rx LPunknown30SUPPLYING
REMEDYREPACK INC.repackager27SUPPLYING
Ascend Laboratories, LLCunknown24SUPPLYING
Asclemed USA, Inc.unknown23SUPPLYING
HAWAII REPACK, INC.repackager20SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown19SUPPLYING
Preferred Pharmaceuticals Inc.unknown18SUPPLYING
Sportpharm LLCunknown14SUPPLYING
Northwind Health Company, LLCunknown11SUPPLYING
Aurobindo Pharma Limitedunknown5SUPPLYING
Direct_Rxunknown5SUPPLYING

+ 16 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 24, 2020
    RECALLRecall (Class II): Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle w…

    CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits. — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the U.S. and Puerto Rico.

  • Aug 24, 2020
    RECALLRecall (Class II): Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when…

    Sub-Potent Drug: Out of specification test results for potency (below specification). — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the U.S. and Puerto Rico.

  • Aug 24, 2020
    RECALLRecall (Class II): Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle w…

    CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits. — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the U.S. and Puerto Rico.